Perinatal Decision Making for Preterm Infants with Congenital Heart Disease: Determinable Risk Factors for Mortality

Stephanie Lynema1, Carlen G Fifer2, Naomi T Laventhal3

  • 1Division of Neonatology, University of Tennessee Medical Center, 1930 Alcoa Highway, Suite 145, Knoxville, TN, 37920, USA.

Pediatric Cardiology
|April 3, 2016
PubMed

Insights

For premature infants with congenital heart disease, survival is 46%. Key mortality risk factors include gestational age under 32 weeks, birth weight under 1500g, and extra-cardiac anomalies, guiding parental decisions on intensive care.

Area of Science:

  • Neonatal care
  • Pediatric cardiology
  • Congenital heart disease (CHD) outcomes

Background:

  • Deciding between intensive care and comfort care for premature infants with CHD is challenging.
  • Lack of defined outcome data complicates counseling for expectant parents.

Purpose of the Study:

  • To evaluate outcomes in premature infants with CHD receiving intensive care.
  • To inform expectant parents regarding intensive versus palliative care decisions at birth.

Main Methods:

  • Retrospective cohort study of infants born <34 weeks with critical or severe CHD requiring surgery.
  • Analysis of survival rates and risk factors for mortality.

Main Results:

  • Overall survival was 46% among 54 infants.
  • 74% of non-survivors died before surgical repair (median age 24 days).
  • Infants <32 weeks gestational age, birth weight <1500g, or with extra-cardiac anomalies had lower survival rates.

Conclusions:

  • Gestational age <32 weeks, birth weight <1500g, and extra-cardiac anomalies are significant prenatal risk factors for mortality.
  • Most deaths occurred before surgery, while most survivors reached surgical repair.
  • These findings may support a trial of intensive care for some families.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
419
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
652
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
426
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
359